Maintaining community-based cohorts in sub-Saharan Africa: An evaluation of participant attrition in SchistoTrack

Abstract

Background: Understanding participant attrition in longitudinal studies is essential for maintaining cohorts, establishing targeted interventions, and assessing potential biases introduced in study analyses. Yet, limited metrics, models, and long-term assessments exist for the evaluation of community-based cohorts in sub-Saharan Africa. Methods: We prospectively assessed participant attrition in the SchistoTrack cohort. A total of 2844 individuals aged 5-92 years were examined from 1445 randomly sampled households across three rural Ugandan districts. Baseline data on sociodemographics, medical history, spatial factors, and clinical examinations were collected in 2022, with annual and seasonal follow-ups analysed to 2024. Profiles of attriters and rejoiners were established with logistic regressions, while the timing of the first attrition event was analysed in multinomial models. Annual community engagement was conducted. Findings: Overall attrition rates were stable across the years ranging from 21-24.8%. Attriter profiles were established within the first year, with only borderline significant factors identified. Home ownership, compared to renting was negatively related to attrition (0.773; CI 0.599-0.998). And, each additional household member reduced the likelihood of attrition (0.923; CI 0.863-0.987). Higher education was positively associated with attrition (1.077; CI 1.047-1.108). Fishermen were not more likely than other individuals to have an attrition event, either overall or seasonally. 40.1% (240/598) of participants who dropped out from the first major follow-up rejoined the study at the following timepoint. Schistosome infection and the need for schistosomiasis-related medical referrals were not associated with later attrition when compared to uninfected individuals and individuals with referrals for ancillary causes or no needed referral. Communicating clinical findings and adjusting incentives across the years did not negatively impact study participation. Interpretation: By providing metrics and models for tracking attrition, our attrition analysis framework can guide the design and evaluation of community-based cohorts in rural sub- Saharan Africa.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

GFC received funding from the Wellcome Trust Institutional Strategic Support Fund (204826/Z/16/Z) and John Fell Fund as part of the SchistoTrack Project, Robertson Foundation Fellowship, and UKRI EPSRC Award (EP/X021793/1). This research was funded in whole, or in part, by the UKRI [EP/X021793/1]. For the purpose of Open Access, the author has applied a CC-BY public copyright licence to any Author Accepted Manuscript version arising from this submission.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Data collection and use were reviewed and approved by Oxford Tropical Research Ethics Committee (OxTREC 509-21), Vector Control Division Research Ethics Committee of the Uganda Ministry of Health (VCDREC146), and Uganda National Council of Science and Technology (UNCST HS 1664ES).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

Participant data is not available due to the identifiable nature of the participant characteristics and ongoing nature of the cohort. Code is available from the authors upon request.

留言 (0)

沒有登入
gif